Cary Street Partners Investment Advisory’s Gritstone bio, Inc. Common Stock GRTS Stock Holding History

Cary Street Partners Investment Advisory’s Portfolio GRTS Stock Details GRTS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-1,000	Closed	-$1.72K	–	1848
2023 Q3	$1.72K	Hold	1,000	–	–	﹤0.01%	1682
2023 Q2	$1.95K	Hold	1,000	–	–	﹤0.01%	1593
2023 Q1	$2.78K	Hold	1,000	–	–	﹤0.01%	1453
2022 Q4	$3.45K	Buy	+1,000	New	+$2.85K	﹤0.01%	1408

Other funds holding GRTS

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

VVM

Versant Venture Management San Francisco, California $163M AUM 240.43% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

FLSM

Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return

Cary Street Partners Investment Advisory's GRTS Position: Q4 2023 in Review

Cary Street Partners Investment Advisory sold out of Gritstone bio, Inc. Common Stock (GRTS) in Q4 2023, closing a stake of 1,000 shares — an estimated $1.72K sold.

Cary Street Partners Investment Advisory first reported a position in GRTS in Q4 2022 and held it in 4 quarters. The position peaked at $3.45K in Q4 2022. 88 funds tracked by Wall St. Rank hold GRTS as of Q4 2023.

Cary Street Partners Investment Advisory reported no remaining Gritstone bio, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
Cary Street Partners Investment Advisory sold 1,000 Gritstone bio, Inc. Common Stock shares in Q4 2023, an estimated $1.72K.
Cary Street Partners Investment Advisory first reported a position in Gritstone bio, Inc. Common Stock in Q4 2022 and held it in 4 quarters.
Cary Street Partners Investment Advisory's Gritstone bio, Inc. Common Stock position peaked at $3.45K in Q4 2022.
88 funds tracked by Wall St. Rank held Gritstone bio, Inc. Common Stock as of Q4 2023.

Based on Cary Street Partners Investment Advisory's 13F filing for Q4 2023, filed 5 Feb 2024.